CDEK
← All organizations

AcelRx Pharmaceuticals, Inc.

For profitWebsite ↗

Also known as: ACELRX PHARMS | Chief Medical Officer, AcelRx Pharmaceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2008

First marketed drug

Nov 2, 2018

Last known activity

Sep 1, 2016

Acquired by Juventas Therapeutics, Inc. on Apr 1, 2009

Timeline

2000s

  1. Jul 1, 2005

    AcelRx Pharmaceuticals, Inc.— Founded

  2. Apr 1, 2009

    Juventas Therapeutics, Inc.— Acquired By

2010s

  1. Nov 2, 2018

    sufentanil— NDA Secondary Org

Drugs by trial phase (4 distinct, 17 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (28)

Details

Founded
Redwood City, CA, US Jul 1, 2005
Last known activity
Sep 1, 2016